Literature DB >> 5595

Interrelationship between catecholamine-stimulated formation of adenosine 3',5'-monophosphate in cerebellar slices and inhibitory effects on cerebellar Purkinje cells: antagonism by neuroleptic compounds.

P Skolnick, J W Daly, R Freedman, B J Hoffer.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1976        PMID: 5595

Source DB:  PubMed          Journal:  J Pharmacol Exp Ther        ISSN: 0022-3565            Impact factor:   4.030


× No keyword cloud information.
  6 in total

1.  Systemic phenoxybenzamine but not beta-adrenergic antagonists block noradrenergic inhibition of cerebellar Purkinje and hippocampal pyramidal neurons.

Authors:  D A Staunton; T H Svensson; G E Chouvet; G R Siggins; F E Bloom
Journal:  J Neural Transm       Date:  1988       Impact factor: 3.575

2.  Interactions of a neuroleptic drug (fluphenazine) with catecholamines in hippocampus.

Authors:  M R Palmer; R Freedman; T V Dunwiddie
Journal:  Psychopharmacology (Berl)       Date:  1982       Impact factor: 4.530

3.  3-Methoxy-4-hydroxyphenylglycol excretion in acutely schizophrenic patients during a controlled clinical trial of the isomers of flupenthixol.

Authors:  M H Joseph; H F Baker; E C Johnstone; T J Crow
Journal:  Psychopharmacology (Berl)       Date:  1979-06-28       Impact factor: 4.530

4.  Electrophysiologic interactions of antipsychotic drugs with central noradrenergic pathways.

Authors:  J Marwaha; B J Hoffer; H M Geller; R Freedman
Journal:  Psychopharmacology (Berl)       Date:  1981       Impact factor: 4.530

5.  Exaggerated norepinephrine-stimulated accumulation of cyclic AMP in vitro in cerebellar slices from pcd mutant mice following Purkinje cell loss.

Authors:  M J Schmidt; B Ghetti
Journal:  J Neural Transm       Date:  1980       Impact factor: 3.575

6.  Antagonism of phencyclidine action by metaphit in rat cerebellar Purkinje neurons: an electrophysiological study.

Authors:  Y Wang; M Palmer; R Freedman; B Hoffer; M V Mattson; R A Lessor; K C Rice; A E Jacobson
Journal:  Proc Natl Acad Sci U S A       Date:  1986-04       Impact factor: 11.205

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.